Deutsche Bank’s Bicycle Therapeutics BCYC Stock Holding History

Deutsche Bank’s Portfolio BCYC Stock Details BCYC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,417	Closed	-$54.5K	–	3616
2025 Q1	$54.5K	Hold	6,417	–	–	﹤0.01%	3363
2024 Q4	$89.8K	Sell	6,417 -1,653	-20%	-$35.4K	﹤0.01%	3317
2024 Q3	$183K	Hold	8,070	–	–	﹤0.01%	2967
2024 Q2	$163K	Hold	8,070	–	–	﹤0.01%	2923
2024 Q1	$201K	Sell	8,070 -302	-4%	-$6.42K	﹤0.01%	2814
2023 Q4	$151K	Sell	8,372 -87,998	-91%	-$1.46M	﹤0.01%	3019
2023 Q3	$1.94M	Buy	96,370 +88,000	+1,051%	+$2.01M	﹤0.01%	1374
2023 Q2	$214K	Hold	8,370	–	–	﹤0.01%	2841
2023 Q1	$178K	Hold	8,370	–	–	﹤0.01%	3065
2022 Q4	$248K	Sell	8,370 -6,480	-44%	-$174K	﹤0.01%	2859
2022 Q3	$345K	Buy	+14,850	New	+$353K	﹤0.01%	2610
2021 Q4	–	Sell	-1	Closed	–	–	4249
2021 Q3	$0	Hold	1	–	–	﹤0.01%	4408
2021 Q2	$0	Buy	+1	New	+$30	﹤0.01%	4599

Other funds holding BCYC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Deutsche Bank's BCYC Position: Q2 2025 in Review

Deutsche Bank sold out of Bicycle Therapeutics (BCYC) in Q2 2025, closing a stake of 6,417 shares — an estimated $54.5K sold.

Deutsche Bank first reported a position in BCYC in Q2 2021 and held it in 13 quarters. The position peaked at $1.94M in Q3 2023. 110 funds tracked by Wall St. Rank hold BCYC as of Q2 2025.

Deutsche Bank reported no remaining Bicycle Therapeutics position as of Q2 2025 after selling out during the quarter.
Deutsche Bank sold 6,417 Bicycle Therapeutics shares in Q2 2025, an estimated $54.5K.
Deutsche Bank first reported a position in Bicycle Therapeutics in Q2 2021 and held it in 13 quarters.
Deutsche Bank's Bicycle Therapeutics position peaked at $1.94M in Q3 2023.
110 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.